117 related articles for article (PubMed ID: 19747705)
1. Direct imaging of the disruption of hepatitis C virus replication complexes by inhibitors of lipid metabolism.
Lyn RK; Kennedy DC; Sagan SM; Blais DR; Rouleau Y; Pegoraro AF; Xie XS; Stolow A; Pezacki JP
Virology; 2009 Nov; 394(1):130-42. PubMed ID: 19747705
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor alpha antagonism inhibits hepatitis C virus replication.
Rakic B; Sagan SM; Noestheden M; Bélanger S; Nan X; Evans CL; Xie XS; Pezacki JP
Chem Biol; 2006 Jan; 13(1):23-30. PubMed ID: 16426968
[TBL] [Abstract][Full Text] [Related]
3. The influence of cholesterol and lipid metabolism on host cell structure and hepatitis C virus replication.
Sagan SM; Rouleau Y; Leggiadro C; Supekova L; Schultz PG; Su AI; Pezacki JP
Biochem Cell Biol; 2006 Feb; 84(1):67-79. PubMed ID: 16462891
[TBL] [Abstract][Full Text] [Related]
4. 3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV.
Aly HH; Shimotohno K; Hijikata M
Biochem Biophys Res Commun; 2009 Feb; 379(2):330-4. PubMed ID: 19103167
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of lipid droplets induced by the hepatitis C virus core protein.
Lyn RK; Kennedy DC; Stolow A; Ridsdale A; Pezacki JP
Biochem Biophys Res Commun; 2010 Sep; 399(4):518-24. PubMed ID: 20678475
[TBL] [Abstract][Full Text] [Related]
6. Intracellular imaging of HCV RNA and cellular lipids by using simultaneous two-photon fluorescence and coherent anti-Stokes Raman scattering microscopies.
Nan X; Tonary AM; Stolow A; Xie XS; Pezacki JP
Chembiochem; 2006 Dec; 7(12):1895-7. PubMed ID: 17068839
[No Abstract] [Full Text] [Related]
7. Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein.
Sato S; Fukasawa M; Yamakawa Y; Natsume T; Suzuki T; Shoji I; Aizaki H; Miyamura T; Nishijima M
J Biochem; 2006 May; 139(5):921-30. PubMed ID: 16751600
[TBL] [Abstract][Full Text] [Related]
8. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
[TBL] [Abstract][Full Text] [Related]
9. Morphine inhibits intrahepatic interferon- alpha expression and enhances complete hepatitis C virus replication.
Li Y; Ye L; Peng JS; Wang CQ; Luo GX; Zhang T; Wan Q; Ho WZ
J Infect Dis; 2007 Sep; 196(5):719-30. PubMed ID: 17674315
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus induced up-regulation of microRNA-27: a novel mechanism for hepatic steatosis.
Singaravelu R; Chen R; Lyn RK; Jones DM; O'Hara S; Rouleau Y; Cheng J; Srinivasan P; Nasheri N; Russell RS; Tyrrell DL; Pezacki JP
Hepatology; 2014 Jan; 59(1):98-108. PubMed ID: 23897856
[TBL] [Abstract][Full Text] [Related]
11. Overdependence on the host-an Achilles' heel of HCV?
Glenn JS
Hepatology; 2004 Jun; 39(6):1734-5. PubMed ID: 15185316
[No Abstract] [Full Text] [Related]
12. Visualizing hepatitis C virus infections in human liver by two-photon microscopy.
Liang Y; Shilagard T; Xiao SY; Snyder N; Lau D; Cicalese L; Weiss H; Vargas G; Lemon SM
Gastroenterology; 2009 Oct; 137(4):1448-58. PubMed ID: 19632233
[TBL] [Abstract][Full Text] [Related]
13. A recombinant replication-competent hepatitis C virus expressing Azami-Green, a bright green-emitting fluorescent protein, suitable for visualization of infected cells.
Hou W; Aoki C; Yu L; Wen X; Xue Y; Gao B; Liu W; Gao GF; Iwamoto A; Kitamura Y
Biochem Biophys Res Commun; 2008 Dec; 377(1):7-11. PubMed ID: 18786508
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of chemical labeling strategies for monitoring HCV RNA using vibrational microscopy.
Noestheden M; Hu Q; Tonary AM; Tay LL; Pezacki JP
Org Biomol Chem; 2007 Aug; 5(15):2380-9. PubMed ID: 17637957
[TBL] [Abstract][Full Text] [Related]
15. Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infection.
Gardelli C; Attenni B; Donghi M; Meppen M; Pacini B; Harper S; Di Marco A; Fiore F; Giuliano C; Pucci V; Laufer R; Gennari N; Marcucci I; Leone JF; Olsen DB; MacCoss M; Rowley M; Narjes F
J Med Chem; 2009 Sep; 52(17):5394-407. PubMed ID: 19725579
[TBL] [Abstract][Full Text] [Related]
16. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation.
Ye J; Wang C; Sumpter R; Brown MS; Goldstein JL; Gale M
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15865-70. PubMed ID: 14668447
[TBL] [Abstract][Full Text] [Related]
17. Cellular models for the screening and development of anti-hepatitis C virus agents.
Gondeau C; Pichard-Garcia L; Maurel P
Pharmacol Ther; 2009 Oct; 124(1):1-22. PubMed ID: 19555718
[TBL] [Abstract][Full Text] [Related]
18. Investigating the antiviral role of cell death-inducing DFF45-like effector B in HCV replication.
Singaravelu R; Delcorde J; Lyn RK; Steenbergen RH; Jones DM; Tyrrell DL; Russell RS; Pezacki JP
FEBS J; 2014 Aug; 281(16):3751-65. PubMed ID: 24980280
[TBL] [Abstract][Full Text] [Related]
19. Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity.
Zapatero-Belinchón FJ; Ötjengerdes R; Sheldon J; Schulte B; Carriquí-Madroñal B; Brogden G; Arroyo-Fernández LM; Vondran FWR; Maasoumy B; von Hahn T; Gerold G
Cells; 2021 Jun; 10(7):. PubMed ID: 34209751
[TBL] [Abstract][Full Text] [Related]
20. Ethanol enhances hepatitis C virus replication through lipid metabolism and elevated NADH/NAD+.
Seronello S; Ito C; Wakita T; Choi J
J Biol Chem; 2010 Jan; 285(2):845-54. PubMed ID: 19910460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
